Loading stock data…
Loading stock data…
US$109.81
Get one email when INSM crosses your level. Checked every 15 minutes during market hours.
▼ -0.30 (-0.27%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
51.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
1.66
Bullish momentumMACD above its signal line (0.87).
50-day average
107.60
Price aboveShort-term trend reference.
200-day average
150.55
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company concentrates its activities across three key therapeutic areas: respiratory, immunology and inflammation, and neuro and other rare conditions. Insmed’s commercial portfolio is anchored by Arikayce and Brinsupri, both targeting respiratory disorders and serving patients with limited existing treatment options. Beyond its marketed products, …
www.insmed.com9 strong buy · 19 buy · 1 hold · 0 sell · 0 strong sell (29 analysts, 2026-07-01)
9 strong buy · 19 buy · 1 hold · 0 sell · 0 strong sell (29 analysts, 2026-06-01)
9 strong buy · 18 buy · 1 hold · 0 sell · 0 strong sell (28 analysts, 2026-05-01)
9 strong buy · 16 buy · 1 hold · 0 sell · 0 strong sell (26 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | -1 | -0.76 | ✓ Beat |
| 2026-03-13 | 0.05 | 0.07 | ✓ Beat |
| 2026-02-19 | -1.17 | -1.54 | ✗ Miss |
| 2025-10-30 | -1.37 | -1.75 | ✗ Miss |
| 2025-10-17 | 0.66 | 0.69 | ✓ Beat |
| 2025-08-07 | -1.31 | -1.7 | ✗ Miss |
| 2025-05-08 | -1.36 | -1.42 | ✗ Miss |
Companies in the same industry, via Finnhub